Skip to content

Article: Nicotinamide Riboside Increases NAD+ and Protects Neurons in ALS Models: Preclinical Findings

Nicotinamide Riboside Increases NAD+ and Protects Neurons in ALS Models: Preclinical Findings


Synopsis

Amyotrophic lateral sclerosis (ALS) is a disease where motor neurons progressively die. Astrocytes from ALS models can cause motor neuron death in cell cultures. Boosting NAD+ levels or increasing NAD+-dependent enzymes like SIRT3 and SIRT6 protects neurons in these models. In ALS mice, removing the NAD+-consuming enzyme CD38 had no effect, but giving nicotinamide riboside (NR), a NAD+ precursor, slowed motor neuron loss, reduced spinal cord inflammation, improved muscle metabolism, and slightly extended survival. In ALS patients, key NAD+-related enzymes were altered, suggesting this protective pathway is impaired. These findings highlight NR as a promising approach to boost NAD+ and protect neurons in ALS.

Journal

Experimental Neurology

Read more

Cardiovascular Disease

Nicotinamide Riboside Protects the Brain from Hypertension-Related Small Vessel Damage: Preclinical Findings

Synopsis Hypertension can cause damage to small blood vessels in the brain, leading to memory problems and white matter injury, but treatments are limited. In this study, mice with angiotensin-ind...

Read more
Metabolic Health

Neonatal Nicotinamide Riboside and Resveratrol Epigenetically Program White Fat Browning: Preclinical Findings

Synopsis Giving newborn male mice resveratrol (RSV) or nicotinamide riboside (NR) can “program” their white fat to develop brown fat-like features (WAT browning) and improve metabolism later in li...

Read more